Catalym

Catalym

Developing innovative immunotherapies to transform cancer patients’ lives by effectively engaging their own immune systems to combat this malignant disease.

HQ location
Munich, Germany
Launch date
Employees
Enterprise value
$600—900m
Company register number
HRB 226681 (München)
Authorizing premium user...